Serum levels of IL-6 and its mRNA and protein expression in cardiac tissues are significantly increased in patients with cardiac diseases, including heart failure, myocarditis, septic cardiomyopathy, myocardial infarction, and cardiac myxoma (Ikeda et al., 1992). This evidence concerns the gene IL6 and myocarditis.